The platform integrates data from over 50,000 U.S. hospitals and provider organizations via HealthEx, lab results through diagnostic partner Function, and more than 50 wearable devices including Apple Health, Fitbit, and Oura. Microsoft assembled an external panel of 230 physicians from 24 countries for safety and clinical review. The launch puts Microsoft in direct competition with OpenAI's ChatGPT Health and Anthropic's Claude for Healthcare, both launched in January 2026.
Attorneys should monitor this development as a marker of accelerating AI integration into consumer healthcare. Microsoft's analysis of 500,000 de-identified conversations from January 2026 found that nearly one in five involved symptom assessment or condition discussion, with usage spiking during evening and overnight hours when traditional care is unavailable. The company holds ISO/IEC 42001 certification for responsible AI practices and has committed not to use Copilot Health data for model training—commitments that will likely become baseline expectations for competitors and potential regulatory benchmarks as healthcare AI tools proliferate.